Macrogenics (MGNX) Net Cash Flow (QoQ) (2013 - 2026)
Macrogenics (MGNX) Net Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140.59% |
| Dec 31, 2025 | 54.68% |
| Sep 30, 2025 | -239.67% |
| Jun 30, 2025 | 60.06% |
| Mar 31, 2025 | -1,259.25% |
| Dec 31, 2024 | -96.64% |
| Sep 30, 2024 | 2,575.23% |
| Jun 30, 2024 | 117.36% |
| Mar 31, 2024 | -286.30% |
| Dec 31, 2023 | 158.63% |
| Sep 30, 2023 | 83.67% |
| Jun 30, 2023 | -200.11% |
| Mar 31, 2023 | 363.54% |
| Dec 31, 2022 | -60.19% |
| Sep 30, 2022 | 341.79% |
| Jun 30, 2022 | 66.04% |
| Mar 31, 2022 | -13.54% |
| Dec 31, 2021 | -4,396.09% |
| Sep 30, 2021 | 105.29% |
| Jun 30, 2021 | -179.02% |